March 15 (Reuters) - Glaxosmithkline Plc: Skip to main content. Exclusive news, data and analytics for financial market professionals Learn more about Refinitiv. Reuters home. World.

The vaccine is the second GSK intramuscular quadrivalent flu vaccine approved by the FDA in less than a year. In December, the agency gave its approval to Fluarix Quadrivalent, the first-ever ...

GSK's Fluarix Quadrivalent was the first-ever intramuscular influenza vaccine approved by the FDA in December 2012 and is now shipping to customers. "Since the late 1980s, ...

But on top of that, GlaxoSmithKline has uncovered some other effectiveness problems of its own--and now it's recalling a quadrivalent jab in a move that affects 1.7 million doses.

GlaxoSmithKline announced it has begun shipping the 2015-2016 formulation of Fluarix Quadrivalent (influenza virus vaccine) and expects to begin shipping Flulaval Quadrivalent (influenza virus ...

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation ...

GSK's Fluarix Quadrivalent was the first-ever intramuscular influenza vaccine approved by the FDA in December 2012 and is now shipping to customers. "Since the late 1980s, ...

GSK has said it anticipates making only a limited amount of quadrivalent vaccine available this year, although it should be able to supply around 35m doses for the 2014–15 flu season. The new Flulaval ...

GlaxoSmithKline's Fluarix Quadrivalent is the first intramuscular vaccine to protect against four influenza strains. Skip to content. All Sections. Subscribe Now. 75°F. Wednesday, May 7th 2025 ...

GlaxoSmithKline has begun shipment of Fluarix Quadrivalent vaccine, a four-strain intramuscular influenza vaccine, for the 2013-2014 flu season.

Big Pharma giant GlaxoSmithKline (GSK-0.12%) announced in a press statement earlier this week that the Food and Drug Administration has approved its Fluarix Quadrivalent flu vaccine for adults and ...

GlaxoSmithKline says the government agency ordered over 4 million doses which will be distributed to state and local healthcare providers. GSK forecasts selling up to 10 million doses Fluarix ...